Rimas V Lukas Selected Research

Gold

10/2021

A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rimas V Lukas Research Topics

Disease

42	Neoplasms (Cancer) 04/2024 - 12/2006
28	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 07/2009
22	Brain Neoplasms (Brain Tumor) 04/2024 - 07/2009
19	Glioma (Gliomas) 01/2024 - 12/2006
10	Neoplasm Metastasis (Metastasis) 08/2023 - 02/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2014
4	Meningioma (Meningiomas) 04/2024 - 12/2020
4	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2014
3	Epilepsy (Aura) 10/2021 - 01/2016
3	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 01/2018
3	Encephalitis (Encephalitis, Rasmussen) 01/2018 - 01/2014
2	Confusion (Bewilderment) 07/2024 - 03/2017
2	Carcinogenesis 07/2023 - 12/2007
2	Seizures (Absence Seizure) 01/2023 - 01/2018
2	Circulating Neoplastic Cells 01/2023 - 02/2022
2	Hemangioblastoma 01/2023 - 09/2016
2	Lymphoma (Lymphomas) 11/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
2	Disease Progression 01/2019 - 02/2012
2	Lung Neoplasms (Lung Cancer) 09/2014 - 02/2012
1	Overweight 01/2024
1	Altitude Sickness (Mountain Sickness) 01/2024
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Arachnoiditis 01/2023
1	Anemia 01/2023
1	Neurologic Manifestations (Neurological Manifestations) 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Delirium 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Amnesia (Dissociative Amnesia) 01/2021
1	Anterograde Amnesia 01/2021
1	Infarction (Infarctions) 01/2021

Drug/Important Bio-Agent (IBA)

8	Temozolomide (Temodar)FDA LinkGeneric 07/2024 - 02/2012
7	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2023 - 01/2018
5	Bevacizumab (Avastin)FDA Link 12/2021 - 07/2009
4	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2023 - 01/2019
4	EnzymesIBA 12/2022 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2016
4	AntibodiesIBA 01/2018 - 01/2013
3	KynurenineIBA 01/2023 - 12/2015
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 12/2006
3	Interleukin-12 (IL 12)IBA 01/2022 - 01/2019
3	Tryptophan (L-Tryptophan)FDA Link 12/2021 - 12/2015
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2018
3	SteroidsIBA 11/2020 - 01/2018
3	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 10/2020 - 01/2018
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 01/2014
2	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2019
2	TransferasesIBA 01/2023 - 02/2009
2	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2023
2	VaccinesIBA 11/2021 - 01/2020
2	Anticonvulsants (Antiepileptic Drugs)IBA 10/2021 - 01/2018
2	epidermal growth factor receptor VIIIIBA 01/2020 - 04/2018
2	rindopepimutIBA 01/2020 - 04/2018
2	NivolumabIBA 01/2020 - 01/2018
2	atezolizumabIBA 01/2019 - 11/2018
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2018 - 01/2016
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2016 - 01/2013
2	N-Methylaspartate (NMDA)IBA 01/2016 - 01/2014
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2024
1	ivosidenibIBA 12/2023
1	SenotherapeuticsIBA 12/2023
1	CytokinesIBA 07/2023
1	belzutifanIBA 01/2023
1	Albumin-Bound Paclitaxel FDA Link 01/2023
1	snake venom protein C activatorIBA 12/2022
1	Antidepressive Agents (Antidepressants)IBA 05/2022
1	Circulating Tumor DNAIBA 02/2022
1	veledimexIBA 01/2022
1	Complement Factor H (Factor H)IBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Protein Isoforms (Isoforms)IBA 12/2021
1	EmulsionsIBA 11/2021
1	WT1 ProteinsIBA 11/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2021
1	HLA-A Antigens (HLA-A)IBA 11/2021
1	perillyl alcoholIBA 10/2021
1	Nucleic AcidsIBA 10/2021
1	Volatile Oils (Essential Oils)IBA 10/2021
1	GoldIBA 10/2021
1	SilverIBA 10/2021
1	Heroin (Diamorphine)IBA 01/2021
1	Cocaine (Cocaine HCl)IBA 01/2021
1	Opiate AlkaloidsIBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021

Therapy/Procedure

33	Therapeutics 04/2024 - 12/2006
16	Immunotherapy 12/2023 - 06/2015
11	Radiotherapy 01/2023 - 12/2007
7	Drug Therapy (Chemotherapy) 01/2023 - 12/2007
2	Adjuvant Radiotherapy 04/2024 - 01/2019
2	Craniotomy 01/2024 - 07/2011
2	Aftercare (After-Treatment) 12/2023 - 01/2019
1	Adjuvant Chemotherapy 06/2023
1	Drug Tapering 01/2023
1	Re-Irradiation 12/2021
1	Salvage Therapy 12/2021
1	Intravenous Administration 10/2021